| Purification and partial biochemical characterization of a membrane-bound type II-like α-glucosidase from the yeast morphotype of Sporothrix schenckii. | |
| | |
MedLine Citation:
|
PMID: 21927828 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The early steps of glycoprotein biosynthesis involve processing of the N-glycan core by endoplasmic reticulum α-glucosidases I and II which sequentially trim the outermost α1,2-linked and the two more internal α1,3-linked glucose units, respectively. We have demonstrated the presence of some components of the enzymic machinery required for glycoprotein synthesis in Sporothrix schenckii, the etiological agent of human and animal sporotrichosis. However, information on this process is still very limited. Here, a distribution analysis of α-glucosidase revealed that 38 and 50% of total enzyme activity were present in a soluble and in a mixed membrane fraction, respectively. From the latter, the enzyme was solubilized, purified to apparent homogeneity and biochemically characterized. Analysis of the enzyme by denaturing electrophoresis and size exclusion chromatography revealed molecular masses of 75.4 and 152.7 kDa, respectively, suggesting a homodimeric structure. Purified α-glucosidase cleaved the fluorogenic substrate 4-methylumbelliferyl-α-D: -glucopyranoside with high affinity as judged from K(m) and V(max) values of 0.3 μM and 250 nmol of MU/min/mg protein, respectively. Analysis of linkage specificity using a number of glucose α-disaccharides as substrates demonstrated a clear preference of the enzyme for nigerose, an α1,3-linked disaccharide, over other substrates such as kojibiose (α1,2), trehalose (α1,1) and isomaltose (α1,6). Use of selective inhibitors of processing α-glucosidases such as 1-deoxynojirimycin, castanospermine and australine provided further evidence of the possible type of α-glucosidase. Accordingly, 1-deoxynojirimycin, a more specific inhibitor of α-glucosidase II than I, was a stronger inhibitor of hydrolysis of 4-methylumbelliferyl-α-D: -glucopyranoside and nigerose than castanospermine, a preferential inhibitor of α-glucosidase I. Inhibition of hydrolysis of kojibiose and maltose by 1-deoxynojirimycin and castanoespermine was significantly lower than that of nigerose. Taken together, these properties are consistent with a type II-like α-glucosidase probably involved in N-glycan processing. To our knowledge, this is the first report of such an activity in a truly dimorphic fungus. |
| | |
Authors:
|
Blanca I Torres-Rodríguez; Karina Flores-Berrout; Julio C Villagómez-Castro; Everardo López-Romero |
Related Documents
:
|
213338 - Phosphorylation of 1-beta-d-arabinofuranosylcytosine by the cell-free extract of rat as... 22014228 - Catalytic inhibition of eukaryotic topoisomerases i and ii by flavonol glycosides extra... 3631278 - Effects of cadmium on canine renal cortical adenylate cyclase. 197078 - Solubilization and separation of the glucagon receptor and adenylate cyclase in guanine... 9487148 - Biochemical characterization of the 7alpha-hydroxylase activities towards 27-hydroxycho... 16498728 - Kinetics of hydrolysis of acetylthiocholine and acetylcholine by cholinesterases. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-17 |
Journal Detail:
|
Title: Antonie van Leeuwenhoek Volume: - ISSN: 1572-9699 ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-9-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372625 Medline TA: Antonie Van Leeuwenhoek Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Departamento de Biología, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Apartado Postal 187, Guanajuato, 36000, GTO, Mexico. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Phylogenetic and biochemical characterization of the oil-producing yeast Lipomyces starkeyi.
Next Document: Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma.